Phase I, open-label study of olaparib plus cisplatin in patients with advanced solid tumors.
Judith Balmaña
No relevant relationships to disclose
Nadine M. Tung
No relevant relationships to disclose
Steven J. Isakoff
No relevant relationships to disclose
Begoña Graña
No relevant relationships to disclose
Paula D. Ryan
No relevant relationships to disclose
Rezvan Rafi
Employment or Leadership Position - AstraZeneca
Michael Tracy
Employment or Leadership Position - AstraZeneca
Eric Winer
No relevant relationships to disclose
José Baselga
Consultant or Advisory Role - AstraZeneca
Judy Ellen Garber
No relevant relationships to disclose